Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 64

1.

Subdermal Ultrasound Contrast Agent Injection for Sentinel Lymph Node Identification: An Analysis of Safety and Contrast Agent Dose in Healthy Volunteers.

Machado P, Stanczak M, Liu JB, Moore JN, Eisenbrey JR, Needleman L, Kraft WK, Forsberg F.

J Ultrasound Med. 2017 Dec 5. doi: 10.1002/jum.14502. [Epub ahead of print]

PMID:
29205451
2.

Buprenorphine in Neonatal Abstinence Syndrome.

Kraft WK.

Clin Pharmacol Ther. 2017 Nov 6. doi: 10.1002/cpt.930. [Epub ahead of print] Review.

PMID:
29105752
3.

Medication Complications in Extracorporeal Membrane Oxygenation.

Shah AG, Peahota M, Thoma BN, Kraft WK.

Crit Care Clin. 2017 Oct;33(4):897-920. doi: 10.1016/j.ccc.2017.06.010. Review.

PMID:
28887935
4.

Buprenorphine for the Neonatal Abstinence Syndrome.

Kraft WK, Adeniyi-Jones SC, Ehrlich ME.

N Engl J Med. 2017 Sep 7;377(10):997-998. doi: 10.1056/NEJMc1709121. No abstract available.

PMID:
28877016
5.

Tumor necrosis factor inhibitors in psoriatic arthritis.

Mantravadi S, Ogdie A, Kraft WK.

Expert Rev Clin Pharmacol. 2017 Aug;10(8):899-910. doi: 10.1080/17512433.2017.1329009. Epub 2017 May 22. Review.

PMID:
28490202
6.

The Nephrotoxicity of Vancomycin.

Filippone EJ, Kraft WK, Farber JL.

Clin Pharmacol Ther. 2017 Sep;102(3):459-469. doi: 10.1002/cpt.726. Epub 2017 Jun 5. Review.

7.

Buprenorphine for the Treatment of the Neonatal Abstinence Syndrome.

Kraft WK, Adeniyi-Jones SC, Chervoneva I, Greenspan JS, Abatemarco D, Kaltenbach K, Ehrlich ME.

N Engl J Med. 2017 Jun 15;376(24):2341-2348. doi: 10.1056/NEJMoa1614835. Epub 2017 May 4.

8.

Bioactivity of Oral Linaclotide in Human Colorectum for Cancer Chemoprevention.

Weinberg DS, Lin JE, Foster NR, Della'Zanna G, Umar A, Seisler D, Kraft WK, Kastenberg DM, Katz LC, Limburg PJ, Waldman SA.

Cancer Prev Res (Phila). 2017 Jun;10(6):345-354. doi: 10.1158/1940-6207.CAPR-16-0286. Epub 2017 Apr 10.

PMID:
28396341
9.

A Population Pharmacokinetic Model for Vancomycin in Adult Patients Receiving Extracorporeal Membrane Oxygenation Therapy.

Moore JN, Healy JR, Thoma BN, Peahota MM, Ahamadi M, Schmidt L, Cavarocchi NC, Kraft WK.

CPT Pharmacometrics Syst Pharmacol. 2016 Sep;5(9):495-502. doi: 10.1002/psp4.12112. Epub 2016 Sep 17.

10.

Effect of Vorapaxar Alone and in Combination with Aspirin on Bleeding Time and Platelet Aggregation in Healthy Adult Subjects.

Kraft WK, Gilmartin JH, Chappell DL, Gheyas F, Walker BM, Nagalla S, Naik UP, Horrow JC, Wrishko RE, Zhang S, Anderson MS.

Clin Transl Sci. 2016 Aug;9(4):221-7. doi: 10.1111/cts.12405. Epub 2016 Jun 15.

11.

Reversibility of Apixaban Anticoagulation with a Four-Factor Prothrombin Complex Concentrate in Healthy Volunteers.

Nagalla S, Thomson L, Oppong Y, Bachman B, Chervoneva I, Kraft WK.

Clin Transl Sci. 2016 Jun;9(3):176-80. doi: 10.1111/cts.12398. Epub 2016 May 12.

12.

Beta-blocker therapy and impact on outcome after aneurysmal subarachnoid hemorrhage: a cohort study.

Chalouhi N, Daou B, Okabe T, Starke RM, Dalyai R, Bovenzi CD, Anderson EC, Barros G, Reese A, Jabbour P, Tjoumakaris S, Rosenwasser R, Kraft WK, Rincon F.

J Neurosurg. 2016 Sep;125(3):730-6. doi: 10.3171/2015.7.JNS15956. Epub 2016 Jan 22.

PMID:
26799296
13.

Neonatal abstinence syndrome: Pharmacologic strategies for the mother and infant.

Kraft WK, Stover MW, Davis JM.

Semin Perinatol. 2016 Apr;40(3):203-12. doi: 10.1053/j.semperi.2015.12.007. Epub 2016 Jan 12. Review.

14.

A Two-Step Haploidentical Versus a Two-Step Matched Related Allogeneic Myeloablative Peripheral Blood Stem Cell Transplantation.

Gaballa S, Palmisiano N, Alpdogan O, Carabasi M, Filicko-O'Hara J, Kasner M, Kraft WK, Leiby B, Martinez-Outschoorn U, O'Hara W, Pro B, Rudolph S, Sharma M, Wagner JL, Weiss M, Flomenberg N, Grosso D.

Biol Blood Marrow Transplant. 2016 Jan;22(1):141-8. doi: 10.1016/j.bbmt.2015.09.017. Epub 2015 Sep 28.

15.

Population Pharmacokinetic Model of Sublingual Buprenorphine in Neonatal Abstinence Syndrome.

Ng CM, Dombrowsky E, Lin H, Erlich ME, Moody DE, Barrett JS, Kraft WK.

Pharmacotherapy. 2015 Jul;35(7):670-80. doi: 10.1002/phar.1610. Epub 2015 Jul 14.

16.

Pharmacologic and clinical evaluation of posaconazole.

Moore JN, Healy JR, Kraft WK.

Expert Rev Clin Pharmacol. 2015 May;8(3):321-34. doi: 10.1586/17512433.2015.1034689. Review.

17.

Current Therapeutic Research is Now Indexed on PubMed.

van den Anker JN, Allegaert K, Kraft WK.

Curr Ther Res Clin Exp. 2014 Nov 9;76:98. doi: 10.1016/j.curtheres.2014.09.005. eCollection 2014 Dec. No abstract available.

18.

Ethanol pharmacokinetics in neonates and infants.

Marek E, Kraft WK.

Curr Ther Res Clin Exp. 2014 Oct 22;76:90-7. doi: 10.1016/j.curtheres.2014.09.002. eCollection 2014 Dec. Review.

19.

Posaconazole tablet pharmacokinetics: lack of effect of concomitant medications altering gastric pH and gastric motility in healthy subjects.

Kraft WK, Chang PS, van Iersel ML, Waskin H, Krishna G, Kersemaekers WM.

Antimicrob Agents Chemother. 2014 Jul;58(7):4020-5. doi: 10.1128/AAC.02448-13. Epub 2014 May 5.

20.

Poor positive predictive value of McConnell's sign on transthoracic echocardiography for the diagnosis of acute pulmonary embolism.

Vaid U, Singer E, Marhefka GD, Kraft WK, Baram M.

Hosp Pract (1995). 2013 Aug;41(3):23-7. doi: 10.3810/hp.2013.08.1065.

PMID:
23948618

Supplemental Content

Loading ...
Support Center